Erythropoietin stimulates the formation of new red blood cells. Because these cells transport oxygen, Epo can improve the body's supply of this vital gas.
Erythropoietin (Epo) is actually a medication for anemia.According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19. The growth factor could mitigate severe disease progression and protect patients from long-term neurological effects when the SARS-CoV-2 virus attacks the brain.
Initial case studies indicate a positive effect of Epo. The researchers are now planning a randomized clinical trial to systematically investigate the effects of Epo treatment in COVID-19 patients.
Epo is released as a natural reaction to oxygen deficiency. The molecule stimulates the formation of red blood cells and thus improves the supply of oxygen to the brain and muscles.
Animal experiments suggest that Epo acts on areas of the brain stem and spinal cord that control breathing. As a result, breathing improves when there is an oxygen deficiency. Epo also has an anti-inflammatory effect on immune cells and could thus attenuate the frequently exaggerated immune response in COVID-19 patients.
Erythropoietin (Epo) is actually a medication for anemia.According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19. The growth factor could mitigate severe disease progression and protect patients from long-term neurological effects when the SARS-CoV-2 virus attacks the brain.
Initial case studies indicate a positive effect of Epo. The researchers are now planning a randomized clinical trial to systematically investigate the effects of Epo treatment in COVID-19 patients.
Epo is released as a natural reaction to oxygen deficiency. The molecule stimulates the formation of red blood cells and thus improves the supply of oxygen to the brain and muscles.
Animal experiments suggest that Epo acts on areas of the brain stem and spinal cord that control breathing. As a result, breathing improves when there is an oxygen deficiency. Epo also has an anti-inflammatory effect on immune cells and could thus attenuate the frequently exaggerated immune response in COVID-19 patients.
0 Comments